Home > Research . Search . Country . Browse . Small Grants

PSC In The News

RSS Feed icon

Groves keynote speaker at MIDAS symposium, Nov 15-16: "Big Data: Advancing Science, Changing the World"

Shaefer says drop child tax credit in favor of universal, direct investment in American children

Buchmueller breaks down partisan views on Obamacare

More News


Gonzalez, Alter, and Dinov win NSF "Big Data Spokes" award for neuroscience network

Post-doc Melanie Wasserman wins dissertation award from Upjohn Institute

ISR kicks off DE&I initiative with lunchtime presentation: Oct 13, noon, 1430 ISR Thompson

U-M ranked #4 in USN&WR's top public universities

More Highlights

Next Brown Bag

Mon, Oct 24 at noon:
Academic innovation & the global public research university, James Hilton

Helen Levy photo

Medicare Part D and Crowd-Out of Employer-Provided Drug Coverage

a PSC Small Fund Research Project

Investigator:   Helen Levy

The Medicare Part D drug benefit, which went into effect in 2006, included large subsidies to employers to continue providing prescription drug coverage to their Medicare-eligible retirees.
Nonetheless, employers still pay for more than two-thirds of these benefits, so that it is hard to believe that the existence of a publicly subsidized alternative - Part D - will not induce at least some employers to drop this coverage. Substantial "crowd out" of this kind has been associated with the expansions of the Medicaid and SCHIP programs. To the extent that public coverage crowds out private coverage, the program's effectiveness in reducing the number of individuals without coverage is diluted. The project will use data from the Medicare Current Beneficiary Study (MCBS) to estimate the impact of Medicare Part D on the provision by employers of private prescription drug insurance and retiree health benefits in general.

Funding Period: 04/01/2009 to 06/30/2010

Country of Focus: USA

Support PSC's Small Grant Program

Search . Browse